Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

BACKGROUND: Osteoprotegerin (OPG) is a tumour and/or bone derived factor that may protect tumour cells from apoptosis. In this study, we have measured serum OPG levels in untreated prostate cancer patients with advanced prostate cancer compared to patients with organ confined disease and in treated...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Eaton, C, Wells, J, Holen, I, Croucher, P, Hamdy, F
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2004

Những quyển sách tương tự

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
Bằng: Eaton, C, et al.
Được phát hành: (2004)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
Bằng: Holen, I, et al.
Được phát hành: (2002)

Role of osteoprotegerin (OPG) in cancer.
Bằng: Holen, I, et al.
Được phát hành: (2006)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
Bằng: Holen, I, et al.
Được phát hành: (2002)

The role of osteoprotegerin in breast and prostate cancer
Bằng: Holen, I, et al.
Được phát hành: (2002)

OPG is a survival factor for breast- and prostate cancer cells in vitro
Bằng: Holen, I, et al.
Được phát hành: (2002)

Polymorphisms within the osteoprotegerin (OPG) gene are associated with both serum OPG levels and bone mineral density.
Bằng: Miles, L, et al.
Được phát hành: (2004)

Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
Bằng: Gamal B Mohamed, et al.
Được phát hành: (2011-01-01)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Bằng: Holen Ingunn, et al.
Được phát hành: (2009-07-01)

Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis
Bằng: Lili Zhang, et al.
Được phát hành: (2016-11-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
Bằng: Riham Eid, et al.
Được phát hành: (2023-06-01)

Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients
Bằng: Indra Wijaya, et al.
Được phát hành: (2024-01-01)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
Bằng: Croucher, P, et al.
Được phát hành: (2000)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
Bằng: Shipman, C, et al.
Được phát hành: (2002)

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Bằng: Siamak Kazemi-Sufi, et al.
Được phát hành: (2024-09-01)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
Bằng: Shipman, C, et al.
Được phát hành: (2000)

Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
Bằng: Shipman, C, et al.
Được phát hành: (2002)

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
Bằng: Noura N. Alraouji, et al.
Được phát hành: (2024-08-01)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
Bằng: Chan Kai-Ming, et al.
Được phát hành: (2011-07-01)

Osteoprotegerin (OPG): A potential biomarker for adverse cardiovascular events in stable coronary artery disease
Bằng: Syed Muhammad Muneeb Akhtar, et al.
Được phát hành: (2024-07-01)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
Bằng: Waterman, E, et al.
Được phát hành: (2007)

Changes of serum osteoprotegerin level in recurrent urolithiasis
Bằng: A. V. Savilov, et al.
Được phát hành: (2023-10-01)

Analysis of periodontal parameteres and salivary levels of Receptor Activator of NF- κβ Ligand (RANKL) and Osteoprotegerin (OPG) in obese periodontitis patients
Bằng: Cheema, Raheem Ramzan
Được phát hành: (2021)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Bằng: Yao Jing, et al.
Được phát hành: (2011-03-01)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
Bằng: Hamdy, F
Được phát hành: (2005)

Osteoprotegerin and the development of myeloma bone disease
Bằng: Croucher, P, et al.
Được phát hành: (2004)

Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
Bằng: Veselina Goranova-Marinova, et al.
Được phát hành: (2007-07-01)

Enhancing androgen ablation response in metastatic hormone-sensitive prostate cancer: the benefits of transurethral resection of the prostate
Bằng: Yan Zhao, et al.
Được phát hành: (2023-07-01)

Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression
Bằng: Jong-Kwang Kim, et al.
Được phát hành: (2021-12-01)

Osteoprotegerin, sclerostin, and osteocalcin serum levels in thyroid disorder patients
Bằng: F. F. Rija, et al.
Được phát hành: (2021-10-01)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
Bằng: Yen-Liang Chen, et al.
Được phát hành: (2023-10-01)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Bằng: Croucher, P, et al.
Được phát hành: (2003)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
Bằng: Yosra Azizpour, et al.
Được phát hành: (2020-01-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
Bằng: Yosra Azizpour, et al.
Được phát hành: (2020-01-01)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Bằng: Croucher, P, et al.
Được phát hành: (2001)

The Role of procollagen type 1 amino-terminal propertied (P1NP) Cytochrome P450 (CYPs) and Osteoprotegerin (OPG) as Potential Bone function markers in Prostate Cancer Bone Metastasis
Bằng: Yousif Pshtiwan A., et al.
Được phát hành: (2023-01-01)

Serum level of osteoprotegerin in patients with Parkinson’s disease: a preliminary study
Bằng: Marta Piaścik-Gromada, et al.
Được phát hành: (2024-03-01)

Determinant Factors and Added Value of Osteoprotegerin (OPG) to Detect Carotid Intima-Media Thickness (CIMT) in Type 2 Diabetes Mellitus Patient
Bằng: Shirly Elisa Tedjasaputra, et al.
Được phát hành: (2018-06-01)

Osteoprotegerin (OPG) Upregulation Activates Breast Stromal Fibroblasts and Enhances Their Pro-Carcinogenic Effects through the STAT3/IL-6 Signaling
Bằng: Huda K. Al-Nasrallah, et al.
Được phát hành: (2022-10-01)

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
Bằng: Salvador Atilano-Miguel, et al.
Được phát hành: (2022-01-01)